This is a routine tax-withholding sale by a former officer, not a discretionary insider sale. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm the sale was executed.
INSM drugs
INSM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $110.00entry
- T+1 · 12d ago −1.13%α +3.28% · $108.76
- T+5 · 6d ago +9.77%α +10.69% · $120.75
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Sara Bonstein, a former officer of Insmed, filed a Form 144 notice of intent to sell 10,261 shares of common stock. The sale is to satisfy tax withholding obligations upon vesting of restricted stock units and related broker fees, indicating a routine, non-discretionary sale rather than a directional signal.
Key Facts
- Filer: Sara Bonstein, a former officer of Insmed Inc.
- Shares to be sold: 10,261 shares of common stock.
- Reason: Shares sold to satisfy tax withholding obligations upon vesting of Restricted Stock Units and to cover related broker fees.
- Date of proposed sale: November 3, 2026.
- Market cap of Insmed: $24.4 billion.
Financial Impact
10,261 shares; at the company's market cap of $24.4B, this represents a negligible fraction of outstanding shares.
Risk Factors
- None material; the sale is mandatory and non-discretionary.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-069586 |
| Document: 0001628280-26-069586-index.html | 0001628280-26-069586 |
| Document: 0001628280-26-069586.txt | 0001628280-26-069586 |
Track record
24 reports on INSM
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 3, 202613d ago 144 Neutral 2/10 Viewing Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
- Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
- Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers